Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Zurier

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Seminars in Arthritis and Rheumatism|December 13, 2003
Prostaglandins: then and now and nextRobert B Zurier
Journal of Cellular Biochemistry|January 18, 2003
Prospects for cannabinoids as anti-inflammatory agentsRobert B Zurier
Arthritis and Rheumatism|December 14, 2004
Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et alSumner Burstein, Robert B Zurier
Clinics in Liver Disease|January 9, 2003
Liver abnormalities in rheumatic diseasesNancy J Walker, Robert B Zurier
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 21, 2016
Cannabinoids, inflammation, and fibrosisRobert B Zurier, Sumner H Burstein
The AAPS Journal|February 10, 2009
Cannabinoids, endocannabinoids, and related analogs in inflammationSumner H Burstein, Robert B Zurier
Bioorganic & Medicinal Chemistry|May 27, 2014
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activityMark A Tepper, Robert B Zurier, Sumner H Burstein
Life Sciences|July 9, 2004
Ajulemic acid: A novel cannabinoid produces analgesia without a "high"Sumner H Burstein, Matthias Karst, Udo Schneider, et al.
Journal of Leukocyte Biology|January 11, 2007
Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patientsJoan H Pedersen-Lane, Robert B Zurier, David A Lawrence
American Journal of Therapeutics|September 1, 1995
Effect of Misoprostol on Acute and Chronic InflammationRonald G. Rossetti, Christina M. Seiler, Kevin Brathwaite, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Seminars in Arthritis and Rheumatism|December 13, 2003
Prostaglandins: then and now and nextRobert B Zurier
Journal of Cellular Biochemistry|January 18, 2003
Prospects for cannabinoids as anti-inflammatory agentsRobert B Zurier
Arthritis and Rheumatism|December 14, 2004
Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et alSumner Burstein, Robert B Zurier
Clinics in Liver Disease|January 9, 2003
Liver abnormalities in rheumatic diseasesNancy J Walker, Robert B Zurier
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 21, 2016
Cannabinoids, inflammation, and fibrosisRobert B Zurier, Sumner H Burstein
The AAPS Journal|February 10, 2009
Cannabinoids, endocannabinoids, and related analogs in inflammationSumner H Burstein, Robert B Zurier
Bioorganic & Medicinal Chemistry|May 27, 2014
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activityMark A Tepper, Robert B Zurier, Sumner H Burstein
Life Sciences|July 9, 2004
Ajulemic acid: A novel cannabinoid produces analgesia without a "high"Sumner H Burstein, Matthias Karst, Udo Schneider, et al.
Journal of Leukocyte Biology|January 11, 2007
Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patientsJoan H Pedersen-Lane, Robert B Zurier, David A Lawrence
American Journal of Therapeutics|September 1, 1995
Effect of Misoprostol on Acute and Chronic InflammationRonald G. Rossetti, Christina M. Seiler, Kevin Brathwaite, et al.
Pageof 3